A. V. Veretennikova

A. V. Veretennikova

Auto-generated profile, based on publicly available information

A. V. Veretennikova

National Medical Research Center for Therapy and Preventive Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Journal of Reproductive Immunology
Verified
Journal Article
Open access
RSRhoda Mount Sperling
Rhoda Mount Sperling
TKThomas A. Kraus
Thomas A. Kraus
JDJian Ding
Jian Ding
AVAlina Veretennikova
Alina Veretennikova
ELElizabeth Lorde-Rollins
Elizabeth Lorde-Rollins
TCTheresa Chang
Theresa Chang
Chlamydia trachomatis infection is one of the most prevalent bacterial STIs in the USA and worldwide, and women with C. trachomatis infection are at increased risk of acquiring HIV. Because immune activation at the genital mucosa facilitates HIV/SIV infection, C. trachomatis-mediated cytokine induction may contribute to increased HIV transmission in asymptomatic women. To begin to elucidate the mechanisms, we longitudinally analyzed profiles of innate immune factors and HIV infectivity in genital secretions from anatomically specific sites in asymptomatic women during C. trachomatis infection and post-antibiotic treatment. We found higher levels of cytokines and chemokines in endocervical secretions than vaginal secretions. Compared with the convalescent state, G-CSF, IL-1α, and RANTES were elevated in endocervical secretions, IFN-γ and TNF-α were elevated in vaginal secretions, and IFNγ, IL-1β, and MIP1-α were elevated in cervicolavage fluid (CVL), before adjustment of multiple comparisons. Elevated endocervical levels of IP-10 and MCP-1 were associated with the use of hormonal contraception in infected women after successful treatment, suggesting the role of hormonal contraception in inflammation independent of STIs. Importantly, soluble factors found in endocervical secretions during infection enhanced HIV infectivity while no difference in HIV infectivity was found with vaginal secretions or CVL during infection or at convalescence. Taken together, the profiles of immune mediators and in vitro HIV infectivity indicate that the endocervical and vaginal mucosa are immunologically distinct. Our results underscore the importance of considering anatomical site and local sampling methodology when measuring mucosal responses, particularly in the presence of C. trachomatis infection.

17 April 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AKA. V. Kontsevaya
A. V. Kontsevaya
AVA. V. Veretennikova
A. V. Veretennikova
ARA. B. Rozanov
A. B. Rozanov
MKM. B. Khudyakov
M. B. Khudyakov
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To evaluate a 1-year outpatient management of patients after myocardial infarction (MI) aged <75 years according to a Russian multicenter study, as well as to assess compliance with recommendations on the frequency of visiting specialists and the performance of diagnostic examinations.Material and methods. This observational study includes a representative sample of MI patients admitted to 16 clinics in 13 Russian regions. Patients with MI who were alive the next day after hospitalization aged <75 years were included in the study according to a special randomization scheme. When writing this article, the data from questionnaires of 6 and 12 months after hospitalization were analyzed: the number of visits to doctors of various specialties, hospitalizations, the number of diagnostic procedures performed (electrocardiography (ECG), echocardiography and surgical interventions (percutaneous coronary intervention, coronary artery bypass grafting (CABG)). The study included a cohort of 723 patients who participated in the survey both 6 and 12 months after hospitalization (67% — patients discharged from the hospital), of which 562 (77,7%) were men and 161 (22,3%) — women. Statistical processing was performed using IBM SPSS Statistics v.25 software for Windows.Results. In the first 6 months after MI, 218 (38,8%) men and 62 (38,5%) women visited the cardiologist the recommended number of times. However, 151 (20,9%) people were not monitored by a cardiologist in the first six months. There was a significant increase in the number of people not observed during the second 6 months up to 209 (28,9%) people (p<0,01). Of the 689 interviewed patients, 210 (30,5%) people visited the therapist the recommended number of times in the first six months, while in the second 6 months — 402 (58,4%) patients. It is also reasonable to single out patients who were not monitored by either a cardiologist or a general practitioner into a separate group. In the first 6 months, the total number of unobserved patients was 68 (7,5%), while in the second six months this number increased to 189 (25,9%). The recommended number of ECGs (4 or more times) was performed in 316 (40,4%) patients, while ECG was not performed in 35 (4,5%) patients. Echocardiography 2 or more times was performed in 194 (25,4%) patients. The procedure was not performed in 167 (21,9%) patients. During the first 6 months, 170 (22%) people were hospitalized, while 156 (20,2%) — during the second half of the year. Angioplasty during the first 12 months after discharge from the hospital was performed in 183 (23,1%) patients, CABG — in 41 (5,2%) patients without age and sex differences.Conclusion. Outpatient management of patients aged <75 years 12 months after MI characterized by low compliance with recommendations on the number of cardiologist consultations and diagnostic procedures, which may adversely affect adherence to the recommended drug treatment and lead to a worse prognosis.

1 January 2021 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
ODOxana M. Drapkina
Oxana M. Drapkina
SBS.A. Berns
S.A. Berns
AGAlexander Gorshkov
Alexander Gorshkov
IYI.S. Yavelov
I.S. Yavelov
VSV.N. Shishkova
V.N. Shishkova
NAN.A. Arablinskiy
N.A. Arablinskiy

8 January 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
SBS. A. Burns
S. A. Burns
AGAlexander Gorshkov
Alexander Gorshkov
VSV. N. Shishkova
V. N. Shishkova
LRL. N. Ryzhakova
L. N. Ryzhakova
ETE. Yu. Tatarevich
E. Yu. Tatarevich
In the context of the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is extremely important to study immunogenicity and immune response duration in different vaccines.Aim. As part of a prospective observational study, to study the levels of anti-SARS-CoV-2 S-protein IgG antibodies in individuals vaccinated with the Gam-COVID-Vac and CoviVac vaccines.Material and methods. The data of 93 people who completed the first 3 visits were analyzed, 23 of whom were vaccinated with the Gam-COVID-Vac vaccine and 70 people — with the CoviVac vaccine. We collected blood before the injection of vaccine doses I and II, as well as 42 days after the injection of dose I in order to quantitatively determine IgG levels. The level of anti-SARS-CoV-2 S-protein IgG antibodies was determined using the SARS-CoV-2 IgG ELISA-BEST reagent kit on the InfiniteF50 TECAN system.Results. A significant increase in anti-SARS-CoV-2 S-protein IgG antibodies was observed in those vaccinated with Gam-COVID-Vac. In the group of CoviVac vaccine, an increase in the level anti-SARS-CoV-2 S-protein IgG antibodies in absolute values was recorded, however, this increase did not reach statistical significance.Conclusion. The data obtained show that the level of anti-SARS-CoV-2 S-protein antibodies 42 days after Gam-COVID-Vac vaccination is significantly higher than after CoviVac vaccination. However, an increase in the level of IgG in both groups indicates the ability of both vaccines to stimulate the production of anti-SARS-CoV antibodies.

15 July 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AVA. V. Veretennikova
A. V. Veretennikova
AKA. V. Kontsevaya
A. V. Kontsevaya
VKVladimir Kutsenko
Vladimir Kutsenko
ASA. G. Soplenkova
A. G. Soplenkova
EFElena Filichkina
Elena Filichkina
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To assess the coverage of preventive counseling on the main modifiable cardiovascular risk factors (RFs) in patients after myocardial infarction (MI) and to identify factors associated with increased counseling activity within a year after the coronary event. Material and methods. The study included 1107 patients with MI aged 35-75 years using a special randomization approach. After 6 months, 889 people were interviewed, and after 12 months — 703 people. At the hospital stage, the smoking status and alcohol consumption were clarified using the Cut down, Annoyed, Guilty, Eye-opener (CAGE) questionnaire. After 6 and 12 months, we clarified whether preventive counseling on the main cardiovascular RFs had been carried out. Social status, changes in life history and disease were also clarified to identify factors associated with receiving preventive counseling. Results. Six and twelve months after MI, preventive counseling on smoking cessation was carried out in 63,8 and 58,4% of smoking patients, respectively; on alcohol cessation — in 16,5 and 14,9%. Patients with obesity (odds ratio (OR) 0,7; confidence interval (CI): 0,48-1,0; p=0,053) and type 2 diabetes (OR 0,49; CI: 0,29-0,82; p=0,008) received counseling on smoking cessation significantly less frequently. Smoking patients (OR 2,87; CI: 1,79-4,66; p<0,001) and those with left ventricular ejection fraction <50% (OR 1,6; CI: 1,01-2,56; p=0,048) received counseling on alcohol cessation more frequently. After 6 and 12 months, 71,5 and 71,6% of patients were consulted on dietary issues, while 56,8 and 31,6% of patients on physical activity, respectively. On dietary issues, obese patients received consultations significantly more often (OR 1,51; CI: 1,02-2,25; p=0,04). Patients observed by a cardiologist more often received consultations on healthy eating (OR 2,1; CI: 1,423,12; p<0,001) and physical activity (OR 2,0; CI: 1,35-2,97; p<0,001). Conclusion. The study results revealed a deficit in preventive counseling on the main modifiable cardiovascular risk factors and their complications.

14 July 2023 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
AKA.V. Kontsevaya
A.V. Kontsevaya
AVA.V. Veretennikova
A.V. Veretennikova
VRVyacheslav Rozanov
Vyacheslav Rozanov
MKM.B. Khudyakov
M.B. Khudyakov
PIP.V. Ipatov
P.V. Ipatov
ODOxana M. Drapkina
Oxana M. Drapkina
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить курительное поведение пациентов на протяжении первого года после перенесенного инфаркта миокарда (ИМ) по данным многоцентрового исследования. МАТЕРИАЛ И МЕТОДЫ Настоящее исследование является наблюдательным и включает пациентов с ИМ, госпитализированных в 16 клиник 13 регионов Российской Федерации. В исследование по специальной рандомизационной схеме включены пациенты в возрасте моложе 75 лет с ИМ, которые были живы на следующий день после госпитализации. Проведен анализ данных первичного опроса (сразу после наступления события (ИМ) и опросов через 6 и 12 месяцев после госпитализации: статус и интенсивность курения — количество выкуриваемых сигарет). Статистическая обработка данных выполнена с помощью программного обеспечения IBM SPSS Statistics v.25 для Windows. РЕЗУЛЬТАТЫ Частота текущего курения среди мужчин до наступления ИМ была статистически значимо выше, чем среди женщин (p<0,001) и выше, чем в российской популяции (52,0 и 43,3% соответственно, p<0,001). За период диспансерного наблюдения количество текущих курильщиков среди мужчин сократилось через 6 мес на 21,4% (p<0,001), через 12 мес — на 18,8% (p<0,001); среди женщин — на 50,0% (p=0,058) и 72,2% (p=0,005) соответственно по сравнению с частотой курения до ИМ. Увеличилось количество некурящих мужчин через 6 мес после ИМ на 33,9% (p<0,001), через 12 мес — на 31,3% (p<0,001); количество некурящих женщин за тот же период выросло на 8,6% (p=0,045), а в целом за 12 мес изменения в количестве некурящих женщин не были статистически значимыми. Изменения курительного поведения аналогичной направленности произошли и в возрастных категориях <60 лет и 60—75 лет. Количество заядлых курильщиков среди мужчин с ИМ, выкуривающих более 20 сигарет в сутки, сократилось через 6 мес на 76,6% (p<0,001), через 12 мес — на 90,9% (p<0,001). Среди женщин с ИМ не было заядлых курильщиков. Число мужчин, выкуривающих до 10 сигарет, увеличилось через 6 мес после ИМ на 80,8% (p<0,001), через 12 мес — на 86,0% (p<0,001). Изменения у женщин той же группы не были статистически значимыми. По прошествии 1 года после ИМ продолжали курить 43,3% мужчин и 2,9% женщин. ЗАКЛЮЧЕНИЕ Анализ курительного поведения на протяжении 12-месячного наблюдения за выборкой лиц мужского и женского пола, перенесших инфаркт миокарда, показал, что значительное количество пациентов окончательно не отказались от курения, а лишь уменьшили его интенсивность (количество выкуриваемых сигарет).